Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von María Luisa Sánchez-León und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Service, Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, Un…. Hauptthemen laut MEDLINE: Breast Neoplasms, Myeloid-Derived Suppressor Cells, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PAIDI, Junta de Andalucia, Consejería de Salud y Familias, Junta de Andalucía, University of Seville.
Abstract (Originalsprache)
Breast cancer (BC) continues to be the most diagnosed tumor in women and a very heterogeneous disease both inter- and intratumoral, mainly given by the variety of molecular profiles with different biological and clinical characteristics. Despite the advancements in early detection and therapeutic strategies, the survival rate is low in patients who develop metastatic disease. Therefore, it is mandatory to explore new approaches to achieve better responses. In this regard, immunotherapy arose as a promising alternative to conventional treatments due to its ability to modulate the immune system, which may play a dual role in this disease since the relationship between the immune system and BC cells depends on several factors: the tumor histology and size, as well as the involvement of lymph nodes, immune cells, and molecules that are part of the tumor microenvironment. Particularly, myeloid-derived suppressor cell (MDSC) expansion is one of the major immunosuppressive mechanisms used by breast tumors since it has been associated with worse clinical stage, metastatic burden, and poor efficacy of immunotherapies. This review focuses on the new immunotherapies in BC in the last five years. Additionally, the role of MDSC as a therapeutic target in breast cancer will be described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory Service, Department of Medical Biochemistry, Molecular Biology and Immunology, School of Medicine, Virgen Macarena University Hospital, University of Seville, 41009 Seville, Spain.
- Oncology Service, Virgen Macarena University Hospital, Department of Medicine, School of Medicine, University of Seville, 41009 Seville, Spain.
- Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, 41009 Seville, Spain.
ORCID-Profile: Carlos Jiménez-Cortegana, Carmen Garnacho, Daniel J García-Domínguez, Lourdes Hontecillas-Prieto, Víctor Sánchez-Margalet
Förderung
- PAIDI, Junta de Andalucia
- Consejería de Salud y Familias, Junta de Andalucía
- University of Seville
Zitieren
APA
Sánchez-León, M. L., Jiménez-Cortegana, C., Silva Romeiro, S., Garnacho, C., de la Cruz-Merino, L., García-Domínguez, D. J., Hontecillas-Prieto, L., & Sánchez-Margalet, V. (2023). Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065208
Vancouver
Sánchez-León ML, Jiménez-Cortegana C, Silva Romeiro S, Garnacho C, de la Cruz-Merino L, García-Domínguez DJ, et al. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065208
BibTeX
@article{SnchezLen2023,
author = {Sánchez-León, María Luisa and Jiménez-Cortegana, Carlos and Silva Romeiro, Silvia and Garnacho, Carmen and de la Cruz-Merino, Luis and García-Domínguez, Daniel J and Hontecillas-Prieto, Lourdes and Sánchez-Margalet, Víctor},
title = {Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065208}
}
EUVIMED